Monday, August 20, 2018

EAGAN, Minn., Aug. 17, 2018 /PRNewswire-PRWeb/ -- Charles E. Crutchfield III, MD, and Crutchfield Dermatology (Eagan, Minnesota) recently assisted the veterinary staff with a unique patient, Haps, a sand tiger shark, to help with his scoliosis (abnormal curvature.....   [READ MORE]
BALTIMORE, Aug. 17, 2018 /PRNewswire/ -- They come from Portsmouth Naval Hospital in Virginia, Walter Reed National Military Medical Center in Maryland, Naval Hospital Jacksonville in Florida, and other major pediatric hospitals.....   [READ MORE]
BALTIMORE, Aug. 17, 2018 /PRNewswire/ -- Travelling from every corner of the United States and sometimes the world, critically ill children and their families have found the Believe In Tomorrow Children's House at Johns Hopkins to be a warm and embracing home away from home while undergoing medica.....   [READ MORE]
NEW YORK, Aug. 16, 2018 /PRNewswire/ -- Ember Therapeutics, Inc., a clinical stage biopharmaceutical company focused on the clinical application of Bone Morphogenetic Protein-7 (BMP-7), announced today that it has entered into a letter of intent with   [READ MORE]
HACKENSACK, N.J., Aug. 16, 2018 /PRNewswire/ -- For 20 years, residents of Rockford, Michigan have supported the mission of Parent Project Muscular Dystrophy (PPMD), a nonprofi.....   [READ MORE]

  • Neurovascular Devices Market High Revenue at USD 24,650 mn by 2023 | Therapeutic Application Hemorrhagic & Ischemic Strokes | Worldwide Segmentation by MRFR
  • The Alzheimer's Research and Prevention Foundation (ARPF) Announces Second Brain Longevity® Therapy Training Program in Washington D.C.
  • Image Guided Radiotherapy Market to Experience Unfaltering Growth at 15.8% CAGR to Revolutionize the Healthcare Sector by 2023
  • Disposable Negative Pressure Wound Therapy Devices Market: Global Industry Analysis (2012 - 2016) & Opportunity Assessment (2017 - 2027)
  • Elysium Health™ Announces Exclusive License for Use of Nicotinamide Riboside for the Slowing of Aging and Prevention of Age-Related Diseases from Mayo Clinic and Harvard

  • Information Update - Teva Canada expands recall of valsartan drugs to include additional lots, as a precaution
  • Singapore's first clinical trial approval for T cell engineered (TCR) immunotherapy for treatment of Liver cancer
  • ViewRay Announces Full Exercise of Underwriters' Option to Purchase Additional Shares and Closing of Public Offering of Common Stock
  • Mirati Therapeutics Announces Presentation Of KRAS G12C Chemistry Advances At The 255th American Chemical Society (ACS) National Meeting And Exposition
  • Agenus Receives Second Milestone Payment from Merck

    About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines